EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische Studie

Patient-Reported Outcomes Following Periprosthetic Joint Infection of the Hip and Knee

Laurens Manning iD, Alexander Rofe iD, Eugene Athan iD, Stephen D Gill iD, Piers Yates, Darcie Cooper iD, Joshua S Davis iD, Craig Aboltins, Australasian Society for Infectious Diseases Clinical Research Network

Journal of Bone and Joint Surgery · 2024

DOI: 10.2106/jbjs.23.00717 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Bone and Joint Surgery, 2024. Verfasst von Laurens Manning und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Fiona Stanley Hospital, Murdoch, Australia. Hauptthemen laut MEDLINE: Prosthesis-Related Infections, Patient Reported Outcome Measures, Arthroplasty, Replacement, Hip. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The role of patient-reported outcome measures (PROMs) as tools for monitoring the impact and outcomes of periprosthetic joint infection (PJI) is not well described. This study analyzed the Oxford Hip Score (OHS) or Oxford Knee Score (OKS) in a prospective observational cohort of patients with hip or knee PJI.

Methods

The PIANO (Prosthetic joint Infection in Australia and New Zealand, Observational study) cohort prospectively enrolled patients with newly diagnosed PJI from multiple centers. The OHS and OKS were evaluated at PJI diagnosis (baseline) and at 3, 12, and 24 months. Scores and score changes were examined according to PJI type, patient characteristics, and management. A successful functional outcome at 12 months was defined as an OHS of >38 or OHS of >36 and/or an improvement from baseline of >12 or >9, respectively.

Results

Of the 741 participants, PROMs were available at 12 months for 233 with hip and 342 with knee PJI. Significant improvements (p < 0.0001) were seen at 12 months for both the OHS (24.5 to 36) and OKS (25 to 34), with no further improvement at 24 months. Patients with late-acute PJI had a higher median baseline OHS (35; interquartile range [22 to 46]) and OKS (30 [18 to 41]) than those with early PJI (OHS: 19 [15 to 29]; OKS: 22 [16 to 29.5]) or chronic PJI (OHS: 23 [14 to 34]; OKS 22 [14 to 28]). Logistic regression showed that a clinical cure (adjusted odds ratio [aOR] = 1.88, 95% confidence interval [CI] = 1.28 to 2.76, p = 0.001) and early PJI (aOR = 2.56, 95% CI = 1.64 to 4.07, p < 0.0001) independently predicted a successful functional outcome. Chronic renal impairment (aOR = 0.31, 95% CI = 0.13 to 0.71, p = 0.007), congestive cardiac failure (aOR = 0.41, 95% CI = 0.17 to 0.95, p = 0.04), and clinical signs of inflammation (aOR = 0.53, 95% CI = 0.33 to 0.85, p = 0.009) at diagnosis independently predicted failure to achieve a successful functional outcome.

Conclusions

The OHS and OKS varied significantly at baseline and 12 months according to PJI type, emphasizing the need to consider the PJI type when evaluating treatment success. This study highlights superior functional outcomes associated with early PJI and with achievement of a clinical cure. Level of Evidence: Therapeutic Level II . See Instructions for Authors for a complete description of levels of evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prosthesis-Related InfectionsPatient Reported Outcome MeasuresArthroplasty, Replacement, HipHumansMaleFemaleProspective StudiesAgedMiddle AgedLongitudinal StudiesArthroplasty, Replacement, KneeHip ProsthesisAustraliaKnee ProsthesisTreatment OutcomeNew ZealandAged, 80 and over

Autor:innen und Institutionen

  • Department of Infectious Diseases, Fiona Stanley Hospital, Murdoch, Australia.
  • University of Western Australia School of Medicine, University of Western Australia, Perth, Australia.
  • Department of Infectious Diseases, Northern Health, Epping, Melbourne, Australia.
  • Department of Infectious Diseases, Barwon Health, Geelong, Australia.
  • Centre for Innovation in Infectious Disease and Immunology Research, Geelong, Australia.
  • Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.

ORCID-Profile: Laurens Manning, Alexander Rofe, Eugene Athan, Stephen D Gill, Darcie Cooper, Joshua S Davis

Zitieren

APA

Manning, L., Rofe, A., Athan, E., Gill, S. D., Yates, P., Cooper, D., Davis, J. S., Aboltins, C., & Australasian Society for Infectious Diseases Clinical Research Network (2024). Patient-Reported Outcomes Following Periprosthetic Joint Infection of the Hip and Knee. Journal of Bone and Joint Surgery. https://doi.org/10.2106/jbjs.23.00717

Vancouver

Manning L, Rofe A, Athan E, Gill SD, Yates P, Cooper D, et al. Patient-Reported Outcomes Following Periprosthetic Joint Infection of the Hip and Knee. Journal of Bone and Joint Surgery. 2024. doi:10.2106/jbjs.23.00717

BibTeX
@article{Manning2024,
  author = {Manning, Laurens and Rofe, Alexander and Athan, Eugene and Gill, Stephen D and Yates, Piers and Cooper, Darcie and Davis, Joshua S and Aboltins, Craig and Australasian Society for Infectious Diseases Clinical Research Network, Australasian Society for Infectious Diseases Clinical Research Network},
  title = {Patient-Reported Outcomes Following Periprosthetic Joint Infection of the Hip and Knee},
  journal = {Journal of Bone and Joint Surgery},
  year = {2024},
  doi = {10.2106/jbjs.23.00717}
}
Kostenlos starten →